This federal contract award, valued at $142,053.98, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Illumina, Inc., a manufacturer of genomic sequencing equipment and reagents. The contract is for the provision of laboratory equipment, specifically various Illumina sequencing systems including NextSeq, NovaSeq, MiSeq, and iSeq, as well as associated consumables, sample preparation kits, and bioinformatics products. Illumina has previously been awarded other federal...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,020.00 contract is for the provision of lab supplies, with a period of performance through July 29, 2023. There is no set-aside designation indicated. Illumina has previously received prime federal contract awards and subcontracts from agencies like the National...
This is a firm fixed price purchase order contract awarded to Illumina, Inc., a manufacturer of genomic sequencing and analysis products, by the Centers for Disease Control and Prevention (CDC). The $90,260.40 contract does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies. This award appears to be for the provision of Illumina's sequencing...
This firm fixed-price federal contract award to Illumina, Inc. is for the provision of laboratory equipment, valued at $205,800.00. The contract was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh and has a ceiling value of $205,800.00. The contract does not have a set-aside designation. Based on Illumina's background as a manufacturer and provider of sequencing and genomic analysis solutions, the equipment being provided likely includes various NextSeq, NovaSeq, MiSeq,...
This is a purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Illumina, Inc., a for-profit manufacturer of genomic analysis equipment and reagents. The $137,112.53 firm fixed price contract is for the delivery of laboratory equipment, with no set-aside designation. Illumina has a history of providing sequencing systems and related consumables and services to support genomic research and diagnostics for various federal agencies, including the National...
This federal contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Illumina, Inc. to provide laboratory supplies. The contract has a potential value of $190,565.60 and was awarded on a firm fixed price basis with no set-aside designation. Illumina is a for-profit manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The company has previously received prime federal contract awards from...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $95,931.00 contract is for the delivery of laboratory equipment with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across federal agencies such as the...
This is a firm fixed price contract award to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract provides $97,788.84 for Illumina reagent kits to support genomic sequencing and analysis. The award does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies like the NIH, USDA, and VA for a range of...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The $98,094.00 contract is for the provision of laboratory equipment, with no set-aside designation. Based on Illumina's past federal contract work, the equipment is likely to include Next-Generation DNA sequencing systems, reagents, and related...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $79,283.85 contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has previously received prime and subcontract awards from various federal agencies, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to supply...